New Research Reveals Neurons That Restore Leg Movement After Spinal Injury
A rare group of neurons can reconnect broken spinal circuits and trigger leg muscle activity after spinal cord injury, according to a groundbreaking new study. The discovery could pave the way for more effective stem-cell therapies to treat paralysis.
Published findings demonstrate that certain neurons derived from transplanted neural stem cells can integrate into the spinal cord’s motor networks and relay signals to muscles responsible for walking.
Understanding Spinal Cord Injuries
Spinal cord injuries occur when trauma damages the bundle of nerves that carries signals between the brain and the rest of the body, severing communication with muscles and organs below the injury site. The result is often permanent paralysis, along with a range of severe medical complications.
Despite decades of research, there are currently no FDA-approved therapies that restore lost neurological function after spinal cord injury. This leaves hundreds of thousands of people in the United States living with lifelong disabilities.
How Transplanted Neurons Could Rebuild Lost Pathways
For years, scientists have explored the potential of transplanting neural stem cells into injured spinal cords, hoping that new neurons could replace damaged ones and rebuild lost connections. However, a critical question remained: which cells within those grafts connect to the spinal cord’s walking circuits?
This new study addresses that gap by tracking how transplanted neurons integrate with spinal motor circuits and identifying the specific interneuron subtypes capable of activating leg muscles. The research begins to pinpoint the exact neuron types needed to rebuild these pathways.
“Imagine an electrical circuit with a battery on one end and a light bulb on the other. If the wires between them are disconnected, the light bulb won’t turn on. A spinal cord injury breaks that circuit. What we’re trying to do is place new cells into the middle so they can reconnect the pathway and allow signals to flow again.”
— Jennifer Dulin, Assistant Professor of Biology at Texas A&M University and Senior Author of the Study
Key Findings from the Study
In the study, researchers transplanted neural progenitor cells into injured spinal cords of animal models and examined how the transplanted cells connected to surrounding nerve networks. The focus was on how graft-derived neurons linked to spinal motor circuits controlling the hind limbs.
When a small subset of these transplanted neurons was experimentally activated, the animals’ leg muscles responded—clear evidence that the grafted cells had become part of the spinal cord’s motor circuitry.
The team also found that these crucial interneurons were relatively rare in the transplanted cell population. Leg muscle responses were observed in approximately 20% to 30% of the animals tested.
Dulin emphasized the significance of these results:
“This is meaningful because it shows the potential to recreate these walking neural circuits is there. The next step is understanding why some animals respond to the treatment and others don’t.”
Implications for Future Therapies and Rehabilitation
The findings could guide the development of next-generation regenerative therapies by revealing which specific neurons need to be enriched in transplanted cell populations. This precision could significantly improve the effectiveness of stem-cell treatments for paralysis.
The research also highlights the critical role of rehabilitation in recovery. Newly transplanted neurons are immature and must adapt to the spinal cord’s environment—a process that depends on activity.
“We’re essentially putting newborn neurons into a damaged spinal cord and hoping they’ll grow up and integrate into the existing circuitry. Activity, such as rehabilitation, is crucial for helping these neurons mature and form the right connections.”
— Jennifer Dulin
Next Steps in Spinal Cord Injury Research
While the study marks a significant advancement, researchers acknowledge that more work is needed. The next phase will focus on understanding why some animals respond to the treatment while others do not. This insight could lead to more targeted and effective therapies.
The ultimate goal is to translate these findings into human clinical trials, offering new hope for individuals living with paralysis due to spinal cord injuries.